Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate

PHASE4RecruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

May 30, 2026

Conditions
Epilepsy
Interventions
DRUG

sodium valproate

All three groups are administered twice a day via oral administration. Patients are given different doses based on their body weight and the therapeutic effect in controlling epilepsy.

Trial Locations (1)

421001

RECRUITING

The First Affiliated Hospital of University of South China, Hengyang

All Listed Sponsors
lead

The First Affiliated Hospital of University of South China

OTHER